Harvard Bioscience (HBIO) Raw Materials (2011 - 2026)
Harvard Bioscience (HBIO) posted quarterly Raw Materials of $13.3 million for Q1 2026, down 9.09% year-over-year from $14.7 million in Q1 2025, and up 9.58% quarter-over-quarter from $12.2 million in Q4 2025.
Harvard Bioscience (HBIO) Raw Materials (2011 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Raw Materials for 16 consecutive years, with $13.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Raw Materials fell 9.09% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $13.3 million (down 9.09% YoY), while the FY2025 annual figure was $12.2 million, down 20.28% from the prior year.
- Raw Materials advanced to $13.3 million in Q1 2026 per HBIO's latest filing, from $12.2 million in the prior quarter.
- Across five years, Raw Materials topped out at $19.2 million in Q2 2022 and bottomed at $12.2 million in Q4 2025.
- Historically, Raw Materials has averaged $15.9 million across 5 years, with a median of $15.4 million in 2023.
- Annual changes were most pronounced in 2022 — Raw Materials surged 31.79% — and 2025, when it fell 24.1%.
- Harvard Bioscience's Raw Materials stood at $17.4 million in 2022, then retreated by 11.65% to $15.4 million in 2023, then dropped by 0.9% to $15.3 million in 2024, then retreated by 20.28% to $12.2 million in 2025, then increased by 9.58% to $13.3 million in 2026.
- Business Quant data shows HBIO's Raw Materials at $13.3 million in Q1 2026, $12.2 million in Q4 2025, and $13.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.22 Mn |
| Mar 31, 2026 | 13.34 Mn |
| Dec 31, 2025 | 12.17 Mn |
| Sep 30, 2025 | 13.49 Mn |
| Jun 30, 2025 | 14.76 Mn |
| Mar 31, 2025 | 14.67 Mn |
| Dec 31, 2024 | 15.27 Mn |
| Sep 30, 2024 | 17.77 Mn |
| Jun 30, 2024 | 16.34 Mn |
| Mar 31, 2024 | 15.35 Mn |
| Dec 31, 2023 | 15.41 Mn |
| Sep 30, 2023 | 15.13 Mn |
| Jun 30, 2023 | 15.73 Mn |
| Mar 31, 2023 | 18.06 Mn |
| Dec 31, 2022 | 17.44 Mn |
| Sep 30, 2022 | 16.93 Mn |
| Jun 30, 2022 | 19.21 Mn |
| Mar 31, 2022 | 18.47 Mn |
| Dec 31, 2021 | 18.53 Mn |
| Sep 30, 2021 | 16.96 Mn |